ADC Therapeutics SA — Cash Flow (NYSE:ADCT) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 168.73 M233.38 M136.79 M118.69 M123.83 M 131.9 M Cash from investing activities 2.83 M6.67 M2.51 M3.22 M867 K 354 K Cash from financing activities 494.97 M267.39 M593 K73.88 M97.05 M 92.74 M Free cash flow 168.73 M233.38 M136.79 M115.47 M122.97 M 131.55 M

新闻

ADC Therapeutics向Healthcare Royalty授予权证

ADC Therapeutics grants warrants to Healthcare Royalty

ADC Therapeutics修订与HealthCare Royalty的特许权使用费协议

ADC Therapeutics amends royalty deal with HealthCare Royalty

Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year?

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?

ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why

Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?

ADC Therapeutics SA (ADCT) is a Great Momentum Stock: Should You Buy?

Snowflake, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - ADC Therapeutics (NYSE:ADCT), Capricor Therapeutics (NASDAQ:CAPR)

RBC维持ADC Therapeutics股票"跑赢大盘"评级，强劲试验数据支撑

ADC Therapeutics stock maintains Outperform rating at RBC on strong trial data